SKU(재고 관리 코드):LMA042Ra
Magnetic Luminex Assay Kit for Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc.
Magnetic Luminex Assay Kit for Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc.
Product No.
LMA042Ra
Organism Species
Rattus norvegicus (Rat).
Sample Type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Test Method
Double-antibody Sandwich
Assay Length
3.5h
Detection Range
0.49-500pg/mL
Sensitivity
The minimum detectable dose of this kit is typically less than 0.163 pg/mL.
UOM
1Plex 2Plex 3Plex 4Plex 5Plex 6Plex 7Plex 8Plex
Specificity
This assay has high sensitivity and excellent specificity for detection of Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc..
No significant cross-reactivity or interference between Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc. and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc. and the recovery rates were calculated by comparing the measured value to the expected amount of Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc. in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 94-105 | 101 |
EDTA plasma(n=5) | 85-94 | 90 |
heparin plasma(n=5) | 88-101 | 94 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc. were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc. were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc. and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 87-94% | 79-95% | 81-93% | 79-91% |
EDTA plasma(n=5) | 89-96% | 96-103% | 95-104% | 98-105% |
heparin plasma(n=5) | 88-99% | 87-101% | 78-99% | 86-101% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:GCSF) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
Magazine | Citations |
Scientific Reports | The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264. 7) Resistance to Mycobacterium tuberculosis H37Ra Pubmed:26912204 |
International Journal of Clinical and Experimental Pathology | Low-density neutrophils in severe fever with thrombocytopenia syndrome (SFTS) display decreased function to phagocytose SFTS virus and enhanced capacity to synthesize cytokines ISSN:1936-2625/IJCEP0045334 |
International Immunopharmacology | Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c mice Pubmed: 30974284 |
Mol Immunol | Oridonin alleviates kanamycin-related hearing loss by inhibiting NLRP3/caspase-1/gasdermin D-induced inflammasome activation and hair cell pyroptosis Pubmed:35749835 |
Catalog No. | Related products for research use of Rattus norvegicus (Rat) Organism species | Applications (RESEARCH USE ONLY!) |
APA042Ra61 | Active Colony Stimulating Factor 3, Granulocyte (GCSF) | Cell culture; Activity Assays. |
EPA042Ra61 | Eukaryotic Colony Stimulating Factor 3, Granulocyte (GCSF) | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA042Ra01 | Recombinant Colony Stimulating Factor 3, Granulocyte (GCSF) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA042Ra01 | Polyclonal Antibody to Colony Stimulating Factor 3, Granulocyte (GCSF) | WB; IHC; ICC; IP. |
MAA042Ra21 | Monoclonal Antibody to Colony Stimulating Factor 3, Granulocyte (GCSF) | WB; IHC; ICC; IP. |
SEA042Ra | ELISA Kit for Colony Stimulating Factor 3, Granulocyte (GCSF) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCA042Ra | CLIA Kit for Colony Stimulating Factor 3, Granulocyte (GCSF) | Chemiluminescent immunoassay for Antigen Detection. |
LMA042Ra | Magnetic Luminex Assay Kit for Colony Stimulating Factor 3, Granulocyte (GCSF) ,etc. | Magnetic Luminex Assay for Antigen Detection. |